DK1381611T3 - Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik - Google Patents
Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostikInfo
- Publication number
- DK1381611T3 DK1381611T3 DK02750855T DK02750855T DK1381611T3 DK 1381611 T3 DK1381611 T3 DK 1381611T3 DK 02750855 T DK02750855 T DK 02750855T DK 02750855 T DK02750855 T DK 02750855T DK 1381611 T3 DK1381611 T3 DK 1381611T3
- Authority
- DK
- Denmark
- Prior art keywords
- phthalocyanine
- useful
- photodynamic therapy
- carriers
- vivo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
- A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01106411 | 2001-03-21 | ||
PCT/EP2002/003108 WO2002090361A1 (en) | 2001-03-21 | 2002-03-20 | Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1381611T3 true DK1381611T3 (da) | 2005-10-24 |
Family
ID=8176785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02750855T DK1381611T3 (da) | 2001-03-21 | 2002-03-20 | Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik |
Country Status (14)
Country | Link |
---|---|
US (1) | US7153841B2 (da) |
EP (1) | EP1381611B1 (da) |
JP (1) | JP2004529171A (da) |
CN (1) | CN100351255C (da) |
AT (1) | ATE298341T1 (da) |
AU (1) | AU2002341034B2 (da) |
CA (1) | CA2441386C (da) |
DE (1) | DE60204767T2 (da) |
DK (1) | DK1381611T3 (da) |
ES (1) | ES2244793T3 (da) |
IL (2) | IL158032A0 (da) |
PT (1) | PT1381611E (da) |
WO (1) | WO2002090361A1 (da) |
ZA (1) | ZA200308093B (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1362844T3 (da) | 2001-01-26 | 2008-04-14 | Btg Int Ltd | Benzylaminanalog |
DE60205085T2 (de) | 2002-04-25 | 2006-04-20 | L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. | Metallphthalocyanin-analoge enthaltende antibakterielle Zusammensetzungen |
ITFI20020200A1 (it) | 2002-10-21 | 2004-04-22 | Molteni & C Dei Flii Alitti S P A Societa L | Porfirine meso-sostituite. |
ITFI20050093A1 (it) * | 2005-05-05 | 2006-11-06 | Molteni & C | Processo per la preparazione di cloruri di derivati ftalocianinici comprendenti almeno un gruppo ammonio quaternario |
ITFI20050092A1 (it) | 2005-05-05 | 2006-11-06 | Molteni & C | Derivati ftalocianinici, processo per la loro preparazione, composizioni farmaceutiche che li contengono e loro uso |
EP1904109B1 (en) * | 2005-06-29 | 2013-04-03 | L. MOLTENI & C. dei Fratelli Alitti Società' di Esercizio S.p.A. | Self-sterilizing products |
WO2007009101A2 (en) * | 2005-07-14 | 2007-01-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Tetraazaporphyrin-based compounds and their uses |
CN1939919B (zh) * | 2005-09-30 | 2010-06-09 | 中国科学院福建物质结构研究所 | 一种广谱、低毒性的酞菁类杀菌剂及其制备方法和用途 |
GB0520436D0 (en) * | 2005-10-07 | 2005-11-16 | Photobiotics Ltd | Biological materials and uses thereof |
EP2072584B1 (de) | 2007-12-17 | 2011-05-11 | ILFORD Imaging Switzerland GmbH | Phthalocyanin-Farbstoffe, ihre Herstellung und Verwendung |
US9040687B2 (en) * | 2010-01-22 | 2015-05-26 | Council Of Scientific And Idustrial Research | Process for the preparaton of novel porphyrin derivatives and their use as PDT agents and fluorescence probes |
WO2012086857A1 (ko) * | 2010-12-21 | 2012-06-28 | (주)파낙스이엠 | 광역학 진단 또는 치료를 위한 결합체 및 이의 제조방법 |
ITFI20110166A1 (it) * | 2011-08-05 | 2013-02-06 | Molteni & C | Nuovi fotosensibilizzanti ad uso terapeutico. |
CN103382205B (zh) * | 2012-05-03 | 2015-10-28 | 中国医学科学院生物医学工程研究所 | 骨靶向的酞菁锌及制备方法及用途 |
KR101933620B1 (ko) * | 2012-09-18 | 2018-12-28 | 삼성전자주식회사 | 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법 |
RS65324B1 (sr) | 2013-10-18 | 2024-04-30 | Novartis Ag | Obeleženi inhibitori membranskog antigena specifičnog za prostatu (psma), njihova upotreba kao agenasa za snimanje i farmaceutskih agenasa za lečenje karcinoma prostate |
JP6269946B2 (ja) * | 2014-03-25 | 2018-01-31 | 国立大学法人名古屋大学 | 細菌の増殖抑制 |
CN104262350B (zh) * | 2014-10-09 | 2017-01-18 | 福州大学 | 一种酞菁金属配合物及其制备方法和应用 |
CN105418643B (zh) * | 2015-12-22 | 2017-10-20 | 福州大学 | 一种双边生物素‑酞菁锌轭合物及其制备和应用 |
CN106866721B (zh) * | 2017-03-10 | 2019-03-26 | 江苏省原子医学研究所 | 一种硅酞菁衍生物及其制备生物素受体靶向硅酞菁光敏剂的应用 |
CN108498855B (zh) * | 2018-05-09 | 2021-04-27 | 福州大学 | 一种抗菌止血溶胶及其制备方法 |
WO2021261546A1 (ja) * | 2020-06-24 | 2021-12-30 | 国立大学法人 東京大学 | 光増感色素 |
CN112409365B (zh) * | 2020-12-09 | 2021-11-02 | 福州大学 | 3-磺酸基丙烷巯基修饰酞菁及其制备方法与在制药领域的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0434727A4 (en) * | 1988-09-08 | 1994-08-17 | Ultra Diagnostic Corp | Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
JPH0672873A (ja) * | 1992-08-27 | 1994-03-15 | Nippon Shokubai Co Ltd | 腫瘍治療剤および腫瘍光化学診断薬 |
GB9405970D0 (en) * | 1994-03-25 | 1994-05-11 | Secr Defence | Substituted phthalocyanines |
CN1053906C (zh) * | 1996-10-15 | 2000-06-28 | 福州大学 | 酞菁锌配合物及其制造方法和在制抗癌药中的应用 |
DE19731741A1 (de) * | 1997-07-23 | 1999-01-28 | Deutsches Krebsforsch | Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe |
IT1294325B1 (it) * | 1997-08-14 | 1999-03-24 | Molteni L E C Dei Fratelli Ali | Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici |
CZ20021974A3 (cs) * | 1999-12-08 | 2002-11-13 | Gentian As | Substituované ftalocyaniny, způsob jejich výroby a farmaceutický prostředek obsahující tyto sloučeniny |
JP4139539B2 (ja) * | 2000-01-21 | 2008-08-27 | 富士フイルム株式会社 | 光重合性画像記録材料及び平版印刷版原版 |
PT1164135E (pt) * | 2000-06-15 | 2004-06-30 | Molteni & C Frat Alitti Soc Es | Metal-ftalocianinas substituidas sua preparacao e utilizacao |
-
2002
- 2002-03-20 AU AU2002341034A patent/AU2002341034B2/en not_active Expired
- 2002-03-20 WO PCT/EP2002/003108 patent/WO2002090361A1/en active IP Right Grant
- 2002-03-20 IL IL15803202A patent/IL158032A0/xx unknown
- 2002-03-20 AT AT02750855T patent/ATE298341T1/de active
- 2002-03-20 PT PT02750855T patent/PT1381611E/pt unknown
- 2002-03-20 JP JP2002587440A patent/JP2004529171A/ja active Pending
- 2002-03-20 DK DK02750855T patent/DK1381611T3/da active
- 2002-03-20 ES ES02750855T patent/ES2244793T3/es not_active Expired - Lifetime
- 2002-03-20 DE DE60204767T patent/DE60204767T2/de not_active Expired - Lifetime
- 2002-03-20 CA CA2441386A patent/CA2441386C/en not_active Expired - Lifetime
- 2002-03-20 US US10/472,882 patent/US7153841B2/en not_active Expired - Lifetime
- 2002-03-20 EP EP02750855A patent/EP1381611B1/en not_active Expired - Lifetime
- 2002-03-20 CN CNB028068467A patent/CN100351255C/zh not_active Expired - Lifetime
-
2003
- 2003-09-21 IL IL158032A patent/IL158032A/en active IP Right Grant
- 2003-10-17 ZA ZA200308093A patent/ZA200308093B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200308093B (en) | 2004-07-08 |
EP1381611A1 (en) | 2004-01-21 |
IL158032A0 (en) | 2004-03-28 |
AU2002341034B2 (en) | 2007-06-14 |
US20040156787A1 (en) | 2004-08-12 |
WO2002090361A1 (en) | 2002-11-14 |
PT1381611E (pt) | 2005-11-30 |
CA2441386A1 (en) | 2002-11-14 |
ES2244793T3 (es) | 2005-12-16 |
CA2441386C (en) | 2010-12-21 |
DE60204767T2 (de) | 2006-05-18 |
IL158032A (en) | 2009-09-01 |
DE60204767D1 (de) | 2005-07-28 |
WO2002090361A8 (en) | 2004-05-21 |
CN100351255C (zh) | 2007-11-28 |
EP1381611B1 (en) | 2005-06-22 |
CN1633437A (zh) | 2005-06-29 |
JP2004529171A (ja) | 2004-09-24 |
ATE298341T1 (de) | 2005-07-15 |
US7153841B2 (en) | 2006-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1381611T3 (da) | Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik | |
Hamblin et al. | Can light‐based approaches overcome antimicrobial resistance? | |
Spikes et al. | Photodynamic therapy of tumours and other diseases using porphyrins | |
Chan et al. | Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizer | |
Vahabi et al. | The effect of antimicrobial photodynamic therapy with radachlorin and toluidine blue on streptococcus mutans: an in vitro study | |
CY1120977T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
ATE387450T1 (de) | Meso-substituierte porphyrine | |
Kostron et al. | Photodynamic medicine: From bench to clinic | |
ES2174215T3 (es) | Complejos metalicos que contienen perfluoro-alquilo y su utilizacion en el diagnostico por nmr. | |
DE60029944D1 (de) | Polyamine und ihre therapeutische verwendung | |
ATE259814T1 (de) | Substituierte metallphthalocyaninen, ihre herstellung und verwendung | |
WO2005030254A3 (en) | Conjugates for photodynamic therapy | |
PT1420824E (pt) | Clorinas sulfonadas como fotossensibilizadores | |
DK0906758T3 (da) | Zink-phthalocyaniner og tilsvarende konjugater, deres frembingelse og anvendelse i fotodynamisk terapi og som diagnostiske midler | |
Cheng et al. | Photoradiation therapy: current status and applications in the treatment of brain tumors | |
Gharesi et al. | Effect of photodynamic therapy based on indocyanine green on expression of apoptosis-related genes in human gingival fibroblast cells | |
Wainwright et al. | Comparative photodynamic evaluation of new phenothiazinium derivatives against Propionibacterium acnes | |
Zhang et al. | Electron spin resonance studies on photosensitized formation of hydroxyl radical by C-phycocyanin from Spirulina platensis | |
Przygoda et al. | Cellular Mechanisms of Singlet Oxygen in Photodynamic Therapy | |
WO2005048944A3 (en) | Activatable photodynamic therapy agents | |
PL365279A1 (en) | Biotin-derivates and their conjugates with chelating agents | |
DE602004030661D1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
Songca et al. | Photodynamic therapy: A new light for the developing world | |
RU2345803C2 (ru) | Способ фотоиммунотерапии фотосенсибилизатором, активируемым волновой энергией вне организма человека | |
Songca | Combinations of Photodynamic Therapy against Cancer and Microbial Infections |